Literature DB >> 32274631

Combining Aspartate Aminotransferase-to-Platelet Ratio Index with Future Liver Remnant to Assess Preoperative Hepatic Functional Reserve in Patients with Hepatocellular Carcinoma.

Rong-Yun Mai1,2,3, Jie Zeng2,3, Hua-Ze Lu1,3, Rong Liang3,4, Yan Lin3,4, Xue-Min Piao2,3,4, Xing Gao2,3,4, Guo-Bin Wu1,3, Fei-Xiang Wu1,3, Liang Ma1,3, Bang-de Xiang1,3, Le-Qun Li5,6, Jia-Zhou Ye7,8.   

Abstract

BACKGROUND: Accurate preoperative assessment of hepatic functional reserve is essential for conducting a safe hepatectomy. In recent years, aspartate aminotransferase-to-platelet ratio index (APRI) has been used as a noninvasive model for assessing fibrosis stage, hepatic functional reserve, and prognosis after hepatectomy with a high level of accuracy. The purpose of this research was to evaluate the clinical value of combining APRI with standardized future liver remnant (sFLR) for predicting severe post-hepatectomy liver failure (PHLF) in patients with hepatocellular carcinoma (HCC).
METHODS: Six hundred thirty-seven HCC patients who had undergone hepatectomy were enrolled in this study. The performance of the Child-Pugh (CP) grade, model for end-stage liver disease (MELD), APRI, sFLR, and APRI-sFLR in predicting severe PHLF was assessed using the area under the ROC curve (AUC).
RESULTS: Severe PHLF was found to have developed in 101 (15.9%) patients. Multivariate logistic analyses identified that prealbumin, cirrhosis, APRI score, sFLR, and major resection were significantly associated with severe PHLF. The AUC values of the CP, MELD, APRI, and sFLR were 0.626, 0.604, 0.725, and 0.787, respectively, indicating that the APRI and sFLR showed significantly greater discriminatory abilities than CP and MELD (P < 0.05 for all). After APRI was combined with sFLR, the AUC value of APRI-sFLR for severe PHLF was 0.816, which greatly improved the prediction accuracy, compared with APRI or sFLR alone (P < 0.05 for all). Stratified analysis using the status of cirrhosis and extent of resection yielded similar results. Moreover, the incidence and grade of PHLF were significantly different among the three risk groups.
CONCLUSION: The combination of APRI and sFLR can be considered to be a predictive factor with increased accuracy for severe PHLF in HCC patients, compared with CP grade, MELD, APRI, or sFLR alone.

Entities:  

Keywords:  APRI; FLR; HCC; Hepatic functional reserve; PHLF

Mesh:

Substances:

Year:  2020        PMID: 32274631     DOI: 10.1007/s11605-020-04575-w

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  1 in total

1.  Liver regeneration and restoration of liver function after partial hepatectomy: the relation of fibrosis of the liver parenchyma.

Authors:  S Miyazaki; K Takasaki; M Yamamoto; M Tsugita; T Otsubo
Journal:  Hepatogastroenterology       Date:  1999 Sep-Oct
  1 in total
  4 in total

Review 1.  Issues to be considered to address the future liver remnant prior to major hepatectomy.

Authors:  Yoji Kishi; Jean-Nicolas Vauthey
Journal:  Surg Today       Date:  2020-09-07       Impact factor: 2.549

2.  Artificial neural network model to predict post-hepatectomy early recurrence of hepatocellular carcinoma without macroscopic vascular invasion.

Authors:  Rong-Yun Mai; Jie Zeng; Wei-da Meng; Hua-Ze Lu; Rong Liang; Yan Lin; Guo-Bin Wu; Le-Qun Li; Liang Ma; Jia-Zhou Ye; Tao Bai
Journal:  BMC Cancer       Date:  2021-03-16       Impact factor: 4.430

3.  Preliminary Evidence for a Relationship between Elevated Plasma TNFα and Smaller Subcortical White Matter Volume in HCV Infection Irrespective of HIV or AUD Comorbidity.

Authors:  Natalie M Zahr; Kilian M Pohl; Allison J Kwong; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 6.208

4.  Nomogram for prediction of the international study Group of Liver Surgery (ISGLS) grade B/C Posthepatectomy liver failure in HBV-related hepatocellular carcinoma patients: an external validation and prospective application study.

Authors:  Jia-Zhou Ye; Rong-Yun Mai; Wei-Xing Guo; Yan-Yan Wang; Liang Ma; Bang-de Xiang; Shu-Qun Cheng; Le-Qun Li
Journal:  BMC Cancer       Date:  2020-10-28       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.